PIERRE FABRE MEDICAMENT

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 125135
 
  
 
C07D HETEROCYCLIC COMPOUNDS 47115
 
  
 
C07K PEPTIDES 29107
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11195
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1085
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 742
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 6161
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 693
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4134
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0057,601 NOVEL HUMANIZED ADAM17 ANTIBODYJan 04, 16Mar 01, 18[C07K]
2017/0281,622 DERIVATIVES OF MACROCYCLIC N-ARYL-2-AMINO-4-ARYL-PYRIMIDINE POLYETHERS AS INHIBITORS OF FTL3 AND JAKSep 02, 15Oct 05, 17[A61K, C08G]
2017/0043,031 IGF-1R ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCERApr 27, 15Feb 16, 17[A61K, C07K]
2016/0326,257 NOVEL ANTI ADAM17 ANTIBODY AND ITS USE FOR THE TREATMENT OF CANCERDec 24, 14Nov 10, 16[C07K]
2016/0287,514 MEDICINAL LOZENGE BASED ON IBUPROFEN SODIUM DIHYDRATENov 14, 13Oct 06, 16[A61K]
2016/0143,975 METHOD FOR PRODUCING TRIPTOLIDENov 24, 15May 26, 16[A61K, C12P, A61Q]
2015/0252,114 NOVEL ANTIBODIES INHIBITING C-MET DIMERIZATION AND USES THEREOFMar 17, 15Sep 10, 15[G01N, C07K]
2011/0003,705 NOVEL METHOD FOR GENERATING AND SCREENING AN ANTIBODY LIBRARYDec 04, 08Jan 06, 11[C12Q, C12P, C40B]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9913874 Obtaining a juice of fresh plants by thermomechanical treatment and cosmetic and therapeutic use thereofSep 18, 14Mar 13, 18[A23P, A61K, A23N, A23L, A61Q]
9873715 Macrolides useful as anticancer agentsJan 24, 14Jan 23, 18[C07H]
9862759 Method for generating and screening an antibody libraryDec 04, 08Jan 09, 18[C12Q, C07K]
9687459 Aminocyclobutane derivatives, method for preparing same and the use thereof as drugsSep 12, 16Jun 27, 17[A61K, A01N]
9689862 Antigen binding protein and its use as addressing product for the treatment of cancerNov 05, 12Jun 27, 17[A61K, C12N, G01N, C07K]
9676839 Process for the modulation of the antagonistic activity of a monoclonal antibodyDec 02, 09Jun 13, 17[A61K, C07K]
9669106 Conjugate of monomethyl auristatin F and trastuzumab and its use for the treatment of cancerOct 26, 15Jun 06, 17[A61K, C07K]
9624308 Antigen binding proteinsNov 05, 13Apr 18, 17[A61K, C07K]
9603835 Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastasesSep 12, 12Mar 28, 17[A61K, A61N]
9518120 Anti-CXCR4 antibody and its use for the detection and diagnosis of cancerJul 30, 12Dec 13, 16[G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0218,071 ANTI-cMET ANTIBODYAbandonedSep 07, 16Aug 03, 17[A61K, C07K]
2016/0289,204 GRISEOFULVIN DERIVATIVESAbandonedJun 15, 16Oct 06, 16[C07D]
2016/0106,861 AXL ANTIBODY-DRUG CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCERAbandonedApr 28, 14Apr 21, 16[A61K]
2016/0083,420 DERIVATIVES OF DOLASTATIN 10 AND AURISTATINSAbandonedApr 25, 14Mar 24, 16[A61K, C07K]
2016/0068,566 DERIVATIVES OF DOLASTATIN 10 AND AURISTATINSAbandonedApr 25, 14Mar 10, 16[A61K, C07K]
2016/0068,567 DERIVATIVES OF DOLASTATIN 10 AND AURISTATINSAbandonedApr 25, 14Mar 10, 16[A61K, C07K]
2016/0039,935 NOVEL ANTI-cMET ANTIBODYAbandonedApr 02, 15Feb 11, 16[C07K]
2016/0031,995 NOVEL ANTIBODIES FOR THE TREATMENT OF HIVAbandonedJun 22, 15Feb 04, 16[A61K, C07K]
2015/0336,943 NOVEL BENZODIOXANE-PIPERIDINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS FOR TREATING NEUROPSYCHIATRIC DISORDERSAbandonedJan 07, 14Nov 26, 15[C07D]
2015/0307,613 NOVEL ANTI-cMET ANTIBODYAbandonedFeb 27, 15Oct 29, 15[G01N, C07K]
2015/0306,056 USE OF A DHA ESTER FOR PROPHYLACTIC AND/OR CURATIVE TREATMENT OF DREPANOCYTOSISAbandonedNov 27, 13Oct 29, 15[A61K]
2015/0291,507 PANTHENYL DOCOSAHEXAENEOATE AND ITS USE FOR TREATING AND PREVENTING CARDIOVASCULAR DISEASESAbandonedJun 24, 15Oct 15, 15[C07C]
2015/0157,620 LOZENGES WITH MULTIPLE RELEASE KINETICS FOR ACTIVE INGREDIENTSAbandonedJul 30, 13Jun 11, 15[A61K, B05D]
2014/0295,452 ANTI-CMET ANTIBODY AND ITS USE FOR THE DETECTION AND THE DIAGNOSIS OF CANCERAbandonedJan 24, 14Oct 02, 14[G01N]
2014/0193,329 ANTI-CD151 ANTIBODIES AND THEIR USE IN THE TREATMENT OF CANCERAbandonedOct 09, 13Jul 10, 14[A61K, C07K]
2014/0179,794 LEVOMILNACIPRAN-BASED DRUG FOR FUNCTIONAL RECOVERY AFTER ACUTE NEUROLOGICAL EVENTSAbandonedJul 27, 12Jun 26, 14[A61K]
2014/0170,677 USE OF THE ANTIBODY I-3859 FOR THE DETECTION AND DIAGNOSIS OF CANCERAbandonedJul 30, 12Jun 19, 14[G01N, C07K]
2014/0120,555 ANTI-CXCR4 ANTIBODY WITH EFFECTOR FUNCTIONS AND ITS USE FOR THE TREATMENT OF CANCERAbandonedJun 20, 11May 01, 14[C07K]
2014/0112,911 NOVEL ANTI-CMET ANTIBODYAbandonedJun 01, 11Apr 24, 14[A61K]
2014/0115,727 NOVEL ANTI-cMET ANTIBODYAbandonedAug 29, 13Apr 24, 14[A61K, G01N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.